Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks

Thursday, 29 October 2020

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 488 (CSE: $CURA.C) (OTCQX: $CURLF) (OTC: $MJNA) (CSE: $DIXI_U.C), (OTCQX: $DXBRF)

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 488 (CSE: $CURA.C) (OTCQX: $CURLF) (OTC: $MJNA) (CSE: $DIXI_U.C), (OTCQX: $DXBRF)

Today's podcast sponsored by Cannabis Suisse Corp. (OTC: $CSUI), a fully licensed cannabis cultivation and distribution company in Switzerland

 


Delta, Kelowna, BC, October 29, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/102920-StocksToWatch.mp3

 

Read this  in full at https://www.investorideas.com/news/2020/cannabis-potcasts/10291CURA-CURLF-MJNA-DIXI-DXBRF.asp

 

Hear the investor ideas potcast on Spotify

 

Hear Investor ideas cannabis potcast on iTunes  

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

Today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's facilities for producing cannabis are based in Dietikon, Switzerland, and contain the art surveillance equipment to enable an around the clock webcast. Cannabis Suisse grows high quality, organic cannabis with sustainable, all-natural principles. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse proprietary trademarked MoldStandard is a quantitative microbiology method for analyzing yeast and mold counts in harvested cannabis plants. Cannabis Suisse proprietary trademarked CannaMec is a method for quantifying and removing residual solvents during packaging and storage of CBD products. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.

 

In today’s podcast we look at a few public and private company announcements.

Dixie Brands Inc. (CSE: DIXI.U), (OTCQX: DXBRF) and BR Brands, LLC announced that the previously disclosed reverse takeover transaction of Dixie by BR Brands will be completed on Saturday, October 31, 2020. The combined company has been renamed BellRock Brands Inc. and Dixie's stock symbol on the Canadian Securities Exchange will be changed to "BRCK."  Dixie anticipates that trading of its shares will recommence on or about November 4, 2020. 

 

"We are pleased to announce the upcoming closing of the business combination of BR Brands and Dixie. This transformative transaction was the result of a long-term strategic and value focused approach to building a dominant house of brands within the cannabis sector," said Andrew Schweibold, former Chairman of BR Brands and new Chairman of BellRock.

 

"BellRock unites two of the most established brands in cannabis to create an IP and brand-focused multi-state operator, unique in its strategy and scale. Under BellRock management, the platform is poised for exponential growth, through both M&A and organic R&D, and is purposely built to cater to all of the industry's fastest growing segments."

 

BellRock's portfolio consists of two iconic cannabis brands with deep history, Mary's Brands ("Mary's") and Dixie, as well as two growing, California-based brands, Rebel Coast and Défoncé.

 

Mary's, founded in 2013, is the innovator of cannabis and hemp-infused products for adult use, medical, skincare, wellness and pet markets, and the company's robust library of intellectual property includes a U.S. patent for its acclaimed transdermal technology. Since 2010, Dixie has created a wide array of award-winning beverages, gummies, mints, and taffies as well as two well recognized CBD supplement brands; Aceso Wellness and Therabis. Together, the BellRock brands offer one of the largest spectrums of high-quality consumer packaged goods in the cannabis industry. With 11 brands and over 200 SKUs, BellRock reaches nearly every key consumer group and addresses the needs of a diverse cannabis consumer base. The BellRock manufacturing and distribution footprint continues to expand and currently spans nine states, and the company owns or manages production facilities in its largest markets.

 

"The joining of BR Brands and Dixie is unique in that together, BellRock possesses one of the industry's broadest branded product portfolios catering to the growing and ever-evolving cannabis consumer. Our portfolio is one of the most diversified in the industry and is based on our relentless pursuit of enhancing the consumer experience," said Chuck Smith, Chief Executive Officer of BellRock Brands.

 

BellRock brings together a seasoned leadership team of CPG and cannabis executives with unrivaled financial, capital markets and consumer brands expertise. The Board of Directors of BellRock will be comprised of three nominees of BR Brands and two nominees of Dixie. Andrew Schweibold, previously Chairman of BR Brands, will serve as Chairman of the Board. Chuck Smith, former President and Chief Executive Officer of Dixie, assumes the role of BellRock CEO and joins the BellRock Board. Sat Joshi, former Chief Executive Officer of BR Brands, steps down from the executive position and joins the Board. The Board of Directors also includes Jonathan Rosenthal, Co-Founder and Managing Partner at Rose Capital, and Brian Graham, a seasoned CPG industry executive.

 

BellRock began executing its integration strategy earlier in the year, already yielding operational synergies and unlocking opportunities to grow revenue and cash flow.  The company has already unified its sales team in Colorado and efforts to consolidate manufacturing and sales in other key markets are already underway.

 

"Our mission is to build the first national cannabis house of brands," says Smith, "We aim to accomplish this goal by earning our customers' loyalty and trust, and want BellRock to be known for delivering the highest quality, most consistent and broadest portfolio of cannabis infused products in the industry."

 

BellRock remains committed to growing shareholder value. The company's buy-and-build growth strategy employs a three-pronged approach of enhancing its platform through strategic acquisitions, prioritizing profitable organic revenue growth, and continuously optimizing its costs and capital structure. On a pro forma basis, assuming BR Brands and Dixie had combined as of January 1, 2020, BellRock expects to generate in excess of $40 million in revenue in 2020, with clear plans to deliver exponential revenue and cash flow growth in 2021 and beyond.

 

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) announced today that it has expanded its award-winning line of Select Oil brand products to its 15th state, Illinois - the nation's second-largest adult-use market after California - starting with its Select Elite Live cannabis oil cartridges.

 

Select, America's #1 Cannabis Oil Brand, is a lifestyle brand that was acquired by Curaleaf in February 2020. Select creates a variety of high-quality products that can be found in over a thousand dispensaries across 15 states, including Arizona, California, Colorado, Connecticut, Florida, Illinois, Maryland, Michigan, Nevada, New York, Ohio, Oklahoma, Oregon, Massachusetts, and Maine. As an industry leader, Select takes pride in having some of the most stringent and progressive testing practices in the industry and is committed to continuous innovation to ensure our customers get the best cannabis experience possible.

 

Select Elite Live combines high-quality, high-potency THC oil with live resin extract derived from fresh, frozen flower. Created with a proprietary formula, Elite Live is designed to capture the essence of the living plant with a higher terpene content when compared to a traditional distillate cartridge. The enhanced formula has quickly become a best-seller in every market where it has launched; in Florida alone, sales surpassed $1 million in less than one month. The oil is delivered by Select's unique cartridge technology, which helps to evenly distribute heat and deliver enhanced purity, flavor, and quality.

 

"The Select brand has worked diligently to earn its place as an industry leader and is rapidly becoming the first nationally-recognized cannabis brand," said Joe Bayern, President at Curaleaf. "Illinois is one of the largest adult-use cannabis markets in the country and one that has worked incredibly hard to address the need for reparation and normalization of our industry. We look forward to becoming part of the Illinois community, and serving the patients and consumers with the best in class cannabis consumer products available anywhere."

 

In July 2020, Curaleaf closed on its acquisition of Grassroots, giving the company the opportunity to continue developing innovative products and serving communities across the United States, including Grassroots' native state of Illinois. Select is slated to expand into Pennsylvania early next month. Both Illinois and Pennsylvania are among the largest and fastest-growing cannabis markets in the United States.

 

The Illinois Department of Revenue (IDOR) recently reported that, following the legalization of adult-use cannabis in the state on January 1, marijuana sales have been record-breaking month-over-month, contributing to the $100 million milestone of cannabis tax revenue collected.

 

Select products will be available at many of Illinois' leading dispensaries, including Greenhouse's retail locations in Deerfield, Litchfield, Morris, Mokena and Skokie which will fall under the Curaleaf umbrella and branding pending final regulatory approval. To find a dispensary near you that carries Select products, go to www.selectbetter.com and click "Find Us" for an interactive map of locations.

 

Shoppers Drug Mart Inc. announced the opening of its MediSystem® location in Edmonton.  Owned and operated by Shoppers Drug Mart, MediSystem Inc. is an established specialty pharmacy that provides pharmaceutical dispensing and clinical pharmacy consulting services to the senior housing community and group home facilities.

 

Located at 12215-156 St NW in Edmonton, the new MediSystem Pharmacy is committed to optimizing the health, wellness and safety of all facility residents through the introduction of innovative technologies, continuing education, enhanced clinical services and seamless medication delivery.

 

"Since our inception in 1988 we've been bringing leading edge technology and personal care to long term care residents across Canada," says Sandra Daniel, Vice President of Operations and Clinical at MediSystem Pharmacy. "The opening of our new location in Edmonton will allow us to continue to support the health and well-being of the growing number of seniors in long term care and retirement home facilities through the most advanced, dependable, and personalized pharmacy care. Our investment today also reflects confidence in the future direction of health care in Alberta."

 

The Edmonton MediSystem staff will include a dedicated pharmacy team, including operational and consultant pharmacists to provide on-site, end-to-end support including one-on-one counseling. Providing access to medication 24 hours a day, 7 days a week, 365 days a year, the team will be highly accessible, ensuring that all clinical needs and emergency services are fully covered.  These pharmacists, specializing in senior care, will also provide ongoing training and education that is tailored to optimize resident health outcomes and improve quality of life. Through a series of programs and events, including 1:1 training and hands on learning, MediSystem training focuses on continuous quality improvement processes, disease and drug management, health and wellness as well as other health-related topics.

 

MediSystem Pharmacy has a legacy of being first to market with innovative, technical solutions. Whether it be multi-dose strip packaging, comprehensive digital pen system, ClientCare portal, e-Health solutions or state-of-the-art dispensing machines, MediSystem Pharmacy's technology ensures management of all medication information in a real time environment, resulting in exceptional accuracy.

 

Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary Kannaway® has officially entered the U.S. cannabinol (CBN) market with the release of two new CBN isolate products.

 

Not to be confused with cannabidiol (CBD), which has gained significant popularity over the past few years, CBN is another non-psychoactive cannabinoid found in the cannabis plant. Like the Company’s full-spectrum CBD products, Kannaway®’s CBN products are derived from all-natural hemp.

 

“We’re very excited to become one of the first major hemp-derived product producers to offer CBN,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “It is being researched in several different studies, including a 300 person study just announced on Oct. 28, for its potential sedation and sleep effects.”

 

This new product line includes:

      Kannaway® Pure CBN Liquid: Isolated CBN is combined with sustainably sourced medium-chain triglyceride (MCT) oil, providing an abundant source of essential fatty acids that help to enhance bioavailability naturally. Offered in a 1-ounce bottle with a convenient dropper, each product delivers roughly 30 servings of 10 mg of CBN each.

      Kannaway® Pure CBN Gel Capsules: Isolated CBN and MCT oil are also combined, but are presented in a convenient gel capsule form. They come in a 30-pack, with each gel capsule containing 20 mg of pure CBN.

 

“Though it may be too soon to predict the growth potential for the CBN market, analysts at the Nutrition Business Journal predict that the sleep supplement market will grow 30.1% this year,” said Kannaway CEO Blake Schroeder. “We intend to continue to stay up-to-date with the most recent discoveries in cannabinoid research and offer our customers the latest, most popular ingredients available in sleep science and other categories.”

 


Once again, today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

 

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: Cannabis Suisse Corp. (OTC: CSUI),is a paid featured company on Investorideas.com

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

#Health and #Wellness #Stock Can B Corp (OTCQB: $CANB) Reports Duramed Ultrasound Pain Management and Injury Recovery Solution Expands Availability of Insurance; @CanBCorp

 

#Health and #Wellness #Stock Can B Corp (OTCQB: $CANB) Reports Duramed Ultrasound Pain Management and Injury Recovery Solution Expands Availability of Insurance; @CanBCorp  

 

HICKSVILLE, NY – October 29, 2020 – Investorideas.com Newswire --- Health and wellness stock news - Can B Corp. (OTCQB: CANB) (“Can B” or the “Company”), a diversified health and wellness company, is pleased to announce its expansion for its Duramed Division ultrasound program, the SAM Pro 2.0, to Michigan. The revolutionary Sustained Acoustic Medicine (“SAM”) wellness solution, is proven in accelerating tissue healing and chronic pain reduction and is reimbursable by health insurance companies.

 

Read this news, featuring CANB in full at https://www.investorideas.com/news/2020/lohas/10291CANB-Duramed-Ultrasound.asp

 

This marks the first availability of Duramed beyond its initial success in New York and New Jersey. The opening of Michigan was made possible for no fault insurance via an agreement with Allcare Practice Management.

 

The SAM Pro 2.0 is the first and only FDA cleared wearable low intensity ultrasound device delivering multi-hour treatment to accelerate healing and improve function for musculoskeletal injuries (muscle, tendon, ligament) and reduce chronic pain (without opioid pain medication).

 

Duramed’s marketing strategy is to provide equipment and services to both medical offices as well as direct to consumer. The recurring revenue business model calls for a rental rate per day, which is billed to the insurance company.

 

Duramed is a member of MAGNACARE, an industry organization that insures expedient processing (1st check within 30 days) + arbitration/negotiation support.

 

Marco Alfonsi, Can B’s Chief Executive Officer, commented, “We are thrilled in achieving this milestone of expanding upon our success in New York and New Jersey with this revolutionary solution that addresses a much needed void in the market to accelerate tissue healing and chronic pain reduction. The unique SAM delivery system, recurring revenue business model and our potential to add our proprietary CBD gels, is expected drive our acceleration of revenue at improved gross margins over the next twelve months.”

 

About Can B Corp.

Can B Corp. (OTCQB: CANB) is a Health & Wellness company providing the highest quality cannabidiol (CBD) products under the brands of Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil and Duramed. Can B utilizes multi-channel distribution to reach consumers, including medical facilities, doctor offices, retailers, online and direct. CanB is also an exclusive partner of the LifeGuard® Brand in developing a line of consumer products. The Company is also launching Super Foods, a line of nutritional supplements. Can B Corp. owns and operates an R&D and production facility in Lacey, WA and Green Grow Farms, a licensed hemp grow and cultivation in New York.To learn more about Can B Corp. and our comprehensive line of high quality CBD products, please visit: Canbiola.com and www.CanBCorp.com, follow Can B Corp on Instagram and Facebook, or visit one of the 1,000+ retail outlets that carry Can B Corp. products.

 

For more information about Can B Corp., please visit: CanBCorp.com

 

Twitter @CanBCorp

Instagram @canbcorp

Facebook @ Can B Corp

 

Forward-Looking Statements

Forward-looking statements and risks and uncertainties discussed in this release contain forward-looking statements. The words "anticipate," "believe," "estimate," "may," "intend," "expect," and similar expressions identify such forward-looking statements. Expected, actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. Forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance. The matters discussed herein should not be construed in any way, shape or manner of our future financial condition or stock price. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

 

Investors and Media:

IR@canbiola.com

(917) 658-7878

Paid News -Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure : this news release featuring Can B Corp. (OTCQB: CANB). is a paid for service  on Investorideas.com . More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

About Investorideas.com

https://www.investorideas.com/About/

 

Sign up for free stock news alerts at Investorideas.com

https://www.investorideas.com/Resources/Newsletter.asp

 

 

 

Health, Wellness and Sustainability Stocks Research and News at Investorideas.com - investing ideas for a better world

Like Health, Wellness and Sustainability Stocks? View our LOHAS Stocks Directory

 

Wednesday, 28 October 2020

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 487 (TSXV: $META.V) (CSE: $HITI.C) (OTCQB: $HITIF) (OTC: $CHNC)

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 487 (TSXV: $META.V) (CSE: $HITI.C) (OTCQB: $HITIF) (OTC: $CHNC)

Today's podcast sponsored by Cannabis Suisse Corp. (OTC: $CSUI), a fully licensed cannabis cultivation and distribution company in Switzerland

 


Delta, Kelowna, BC, October 28, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/102820-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/10281META-HITI-HITIF-CHNC.asp

 

Hear the investor ideas potcast on Spotify

 

Hear Investor ideas cannabis potcast on iTunes  

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

Today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's facilities for producing cannabis are based in Dietikon, Switzerland, and contain the art surveillance equipment to enable an around the clock webcast. Cannabis Suisse grows high quality, organic cannabis with sustainable, all-natural principles. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse proprietary trademarked MoldStandard is a quantitative microbiology method for analyzing yeast and mold counts in harvested cannabis plants. Cannabis Suisse proprietary trademarked CannaMec is a method for quantifying and removing residual solvents during packaging and storage of CBD products. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.

 

In today’s podcast we look at a few public and private company announcements.

Meta Growth Corp. (TSXV: META) and High Tide Inc. (CSE: HITI) (OTCQB: HITIF) announced that, at the special meeting of shareholders of META held yesterday, the shareholders of META voted in favour of a special resolution to approve the previously announced proposed business combination pursuant to which High Tide will acquire all of the issued and outstanding common shares of META by way of a plan of arrangement under the Business Corporations Act, as further described in the joint news release issued by META and High Tide on August 21, 2020. The Arrangement required approval by 66 % of the votes cast by META shareholders present in person or represented by proxy at the Meeting.

The Arrangement will create:

       Canada's Largest Cannabis Retailer with $1481 million in Annualized Revenue

       Annual Cost and Operational Synergies of Approximately $8 million to $9 million

       A strong Balance Sheet to Support Growth

 

A total of 102,113,758 META Shares, representing approximately 43.1% of the outstanding META Shares, were represented in person or by proxy at the Meeting. Of the votes cast with respect to the Arrangement, an aggregate of 102,063,111 META Shares were voted in favour of the Arrangement, representing approximately 99.95% of the votes cast on the resolution approving the Arrangement.

 

It is expected that META will apply for a final order from the Court of Queen's Bench of Alberta in respect of the Arrangement on October 28, 2020. Completion of the Arrangement remains subject to receipt of required regulatory and court approvals and other customary closing conditions, which are set out in the arrangement agreement between META and High Tide dated August 20, 2020, a copy of which can be found on the SEDAR profiles of META and High Tide at www.sedar.com. Assuming that the conditions to closing of the Arrangement are satisfied or waived, it is anticipated that the Arrangement will be completed on or before the end of November. Further information about the Arrangement is set forth in the materials prepared by META in respect of the Meeting, which were mailed to META shareholders and filed under META's profile on SEDAR at www.sedar.com.

 

Ikänik Farms, Inc. announced that its wholly owned, CBD-focused subsidiary, Ikänik Life has expanded its action sports family with the addition of snowboarding phenom, Toby Miller.

 

"We are excited to welcome Toby to the Ikänik family and participate in his athletic progression. Toby's love for snowboarding is contagious and his unique approach to competing in the halfpipe makes him a global fan favorite," said Brian Baca, CEO of Ikänik Farms.

 

Toby kicked off his professional career by winning the USASA Nationals title and major sponsors by the age of 13. His career trajectory has continued to over the years, with 2018 being a breakout season for Miller, as he exploded onto the pro scene and made a statement by owning three podiums in major halfpipe competitions. Last season, Toby stole the show at X Games in Aspen, Colorado and won a bronze medal in the men's snowboarding halfpipe event.

 

Toby is focusing on the 2022 Olympic Games in China, with an intense training regimen that is preparing him both mentally and physically to be a leader, in his first of many winter Olympics. He trains with Ikänik Farms board member and US Snowboarding coach JJ Thomas, alongside Shaun White. Toby and Shaun have been riding together since he was 13 years old, and now they will be pushing each other as they each try to earn a spot on the US Olympic halfpipe team this season.

 

"I'm grateful to have partnered up with Ikänik Life CBD to help maintain longevity in the sport I love," said Miller. "Focusing on personal care and training is my top priority."

 

 

China Infrastructure Construction Corp. (OTC:CHNC) announced its merger with Pharmacology University, Inc., a global leader in the field of medical cannabis education that markets its services under the brand Pharmacology University. More to the point, CHNC joining forces with Pharmacology University Inc. and Precision Research Institute has created one of the most complete companies in the cannabis industry. COO Elizabeth Hernandez explains the reasons behind the decision: “While pursuing my dream, I had wanted to unite forces with a company in the Cannabis Industry and that is when I found Pharmacology University. The synergy between the two companies has been superb and we are positioning ourselves to become the high-end authority of the Cannabis Research Industry. Now this journey finally feels complete. Riding this new wave of inspiration, we are deeply committed to produce revenue generating models and building shareholder value.”

 

The merger of CHNC, which is publicly traded on OTC markets under the ticker symbol CHNC, provides the framework for Pharmacology University to expand its focus into cannabis clinical trials and bolstering its education offerings.

 

Founded in 2010, Pharmacology University offers educational products and consulting services in the United States, Puerto Rico, Latin and South America; to train doctors, dispensary owners, growers, lawyers, and other professionals on the palliative and myriad health benefits of cannabis. The company also has partnered with private accredited universities to offer an intensive master's certification program in cannabis science and is now the top international provider of medical cannabis education.

 

In addition to its classroom education, Pharmacology University owns and operates Canna Law Magazine, which is a digital informational piece that provides cultural enrichment to the cannabis entrepreneur. The magazine has biweekly editions and informs the public about the most recent legal cases in the cannabis industry worldwide, also providing strategies by which its readers can avoid finding themselves in legal situations for lack of knowledge. Canna Law Magazine is currently available in English, Spanish, Portuguese, Italian and Arabic, and it is being developed to be published in Chinese and Hindi. To view the magazine, visit www.cannalawmagazine.com.

 

“We want to be pioneers in the search for the truth with actual clinical trials, in regards to how cannabis can be utilized,” says Pharmacology University In-House Legal Counsel, Anne Graham. “Predominantly because the number one problem for people that are set against using cannabis as medicine is simply due to the fact that the cannabis industry has not produced sufficient medical studies,” she says.

 

The global market for medical cannabis (also known as medical marijuana), is expected to reach more than $150 billion annually by 2027, according to a 2019 report by ResearchAndMarkets.com. The anticipated growth is driven in large part by the legalization of cannabis for medical use in Europe, as well as the passage in the U.S. of the Hemp Farming Act of 2018, which legalized hemp, a variety of the Cannabis Sativa species that has less than 0.3% concentration of tetrahydrocannabinol (THC). And although many companies are looking to capitalize on the industry’s projected growth by opening dispensaries, cannabis farms, or manufacturing facilities, Pharmacology University sees limitless opportunities in the education space.

 

Says Dr. Jose Torres, International Medical Director for Pharmacology University, “The endocannabinoid system is represented in every organ and system in the body. That means that at times, we could have deficiencies, just like now and again, our bodies present insufficiencies of minerals and vitamins; accordingly, the human body could also lack endocannabinoids.” Preliminary research indicates that the scarcity of endocannabinoids may be the root of various illnesses, such as epilepsy and even certain types of cancer, he adds. By becoming a pioneer in clinical trials to explore more than 120 cannabis molecules, the newly formed public company aims to equip healthcare professionals and others in the industry with the information and knowledge to help millions of people through the use of cannabis in medical treatments.

 

“We had a vision when we started ten years ago, and 2021 will be our dream becoming a reality,” says Katerin Osuna, International Director of Marketing and Public Relations of Pharmacology University, Magister in Audiovisual Communications and Advertising Content, from the Autónoma University of Barcelona, Spain. “We look forward to being the world leader in cannabis clinical studies.”

 

 

The Mental Health Commission of Canada (MHCC) announced funding 14 community-based research projects that will explore how cannabis use affects underserved populations across the country. Each project will receive funding of up to $100,000 over two years, for a total research investment of $1.4 million.

 

Following the community-based research model, each community under study will lead its own project, participate in every phase of the research, and benefit from positive social change that occurs as a result of the findings.

 

"We are excited to see community-based research projects across Canada that will build capacity and new knowledge, directly benefit communities, and influence public policy," said Dr. Joanna Ochocka, co-director at the Centre for Community Based Research (CCBR). "Collectively, these projects could create stronger, more responsive and supportive communities, especially for those people who lack power or opportunity or who are vulnerable in some way."

 

The projects will address significant gaps in research on cannabis and mental health among Indigenous, Métis, 2SLGBTQ+, senior, immigrant, refugee, ethnocultural, and racialized (IRER) populations, as well as other communities who experience layers of oppression.

One example is the initiative to be undertaken by the Centre for Resilience and Social Development (CRSD). "It's important to examine the link between mental health and cannabis use through social, political and economic lenses," said CRSD project manager Aber Abdulle, who will be looking at how these factors intersect among IRER populations, while striving to bolster community engagement and empower young people.

 

Six of the projects will include initial examinations of cannabis use and mental health in Métis and First Nations communities – some of the first Indigenous-led research of its kind.

"These six projects offer an opportunity for First Nations and Métis to invest in research that honours their own language and culture, the foundation of their world views," said Dr. Carol Hopkins, executive director at the Thunderbird Partnership Foundation. "That's a step in the right direction toward the decolonization of Indigenous knowledges."

 

For Krista Benes, director of the MHCC's mental health and substance use team, this investment marks an exciting step toward more inclusive research. "No one is better equipped to explore the relationship between cannabis and mental health in marginalized communities than the people from those communities. We're all experts in our own right."

 

Quick Facts

       Six of the 14 funded projects are Indigenous-led.

       This research will be the first to examine cannabis use and mental health in Métis communities.

       This research will be among the first Indigenous-led examinations of cannabis use and mental health.

 

Research led by Philippe Lucas, a Graduate Researcher at the University of Victoria and VP Global Patient Research and Access at Tilray, announced that his research has found that medical cannabis use is associated with self-reported reductions and even discontinuation of alcohol use amongst authorized Canadian patients.

 

The results stem from the Canadian Cannabis Patient Survey 2019 (CCPS 2019), a large national cross-sectional survey that gathered comprehensive information on patient demographics, patterns of cannabis use, and self-reported use of prescription drugs, alcohol, tobacco, and illicit drugs before and after medical cannabis initiation from 2102 Canadian medical cannabis patients registered with Tilray, a global pioneer in medical cannabis research and production.

 

"The results of CCPS 2019 add to a growing body of evidence that medical cannabis use is often associated with reductions in the use of other substances, including alcohol, opioids, tobacco and illicit drugs" says Lucas. "Since alcohol is the most prevalent recreational substance in the world, and its use results in significant rates of criminality, morbidity and mortality, these findings may result in improved health outcomes for medical cannabis patients, as well as overall improvements in public health and safety."

 

These results were recently published in the International Journal of Drug Policy in a paper titled Reductions in alcohol use following medical cannabis initiation: results from a large cross-sectional survey of medical cannabis patients in Canada co-authored by Susan Boyd (University of Victoria), M-J Milloy (University of British Columbia) and Zach Walsh (University of British Columbia, Okanagan).

 

Overall, 973 survey participants reported past or current alcohol use, with 419 (44%) reporting decreases in alcohol usage frequency over 30 days, 323 (34%) decreasing the number of standard drinks they had per week, and 76 (8%) reporting no alcohol use at all in the 30 days prior to the survey. Being younger than 55 years and reporting higher rates of alcohol use prior to initiating medical cannabis use were both associated with greater odds of reducing alcohol use, and having an intention to use medical cannabis to reduce alcohol consumption was associated with significantly greater odds of both reducing and ceasing alcohol use altogether. 

 


Once again, today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

 

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: Cannabis Suisse Corp. (OTC: CSUI),is a paid featured company on Investorideas.com

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  

Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

Investor Ideas #Potcasts 608, #Cannabis News and #Stocks on the Move; Interview with President and CEO of RIV Capital (CSE: $RIV.C) (OTC: $CNPOF)

Investor Ideas #Potcasts 608, #Cannabis News and #Stocks on the Move; Interview with President and CEO of RIV Capital (CSE: $RIV.C) (OTC: $C...